PATENT CLAIM ANALYSIS

Application Number: 16232540
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["424", "400000"]

Abstract:
The present invention features compositions comprising a plurality of therapeutic agents wherein the presence of one therapeutic agent enhances the properties of at least one other therapeutic agent. In one embodiment, the therapeutic agents are cystic fibrosis transmembrane conductance regulators (CFTR) such as a CFTR corrector or CFTR potentiator for the treatment of CFTR mediated diseases such as cystic fibrosis. Methods and kits thereof are also disclosed.

Claim (Index 152):
A pharmaceutical composition comprising the solid dispersion of  claim 141 .

Metadata:
- Claim Count in Document: 87.0
- Percentile: 98.0
- Lexical Diversity: 1.4898
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14686117', '15342999', '13942617', '15035969', '16165849']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7034554703952968
- 35 USC 102 Novelty (BERT): 0.5711124801276123
- Combined Prediction Score: 0.6902211713685283
- Mean Citation Score: 359.324886
- Max Citation Score: 621.5099
- Similarity Product: 319.87817703734044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test